The global rare disease diagnostics market (by age group) is sub-segmented as children and adults. The rare disease diagnosis in children was valued at $XX billion in 2017 and is anticipated to reach $XX billion by 2025 growing at a CAGR (2018-2025) of XX% during the forecast period 2018-2025.
The governmental organization are working to improve the diagnosis and treatment of rare disease in children. Retrophin Inc., aims to improve patient café through standardize care models, and establish best diagnosis and treatment practice for rare diseases.
Children’s National Rare Disease Institute (CNRDI) focus exclusively on advancing the care and treatment of children and adults with rare genetic diseases
➢The diagnosis of rare diseases starts in hospitals, as patients actually visit hospitals for the treatment purpose. The goal of the hospitals dealing with rare diseases is to improve the efficiency of the treatment of rare diseases across the different countries.
➢The key objective is to improve diagnosis of rare and multiform diseases by promoting the introduction of next-generation DNA sequencing technologies. The example includes Helsinki University Central Hospital, UPMC Children’s Hospital of Pittsburgh.
About Us:
BIS Research is a global market intelligence, research and advisory company which focuses on those emerging trends in technology which are likely to disrupt the dynamics of the market over the next five (or ten) years.
With over 150 market intelligence reports published annually, BIS Research focuses on various technology verticals such as 3D printing, advanced materials & chemicals, aerospace and defense, automotive, healthcare, electronics & semiconductors, robotics & UAV and other emerging technologies.
Each research report incorporates detailed analysis and subsequent quantification of- market dynamics, market drivers and restraints, opportunities, threats, market shares, current and emerging industry trends as well as detailed competitive landscape and intelligence.
Contact:
39111 PASEO PADRE PKWY STE 313,
FREMONT CA 94538-1686,
E-mail : sales@bisresearch.com
Call Us : +1-510-404-8135
